Loading chat...
GA HB961
Bill
Status
Introduced
2/19/2020
Primary Sponsor
Samuel Park
Click for details
AI Summary
- The Department of Community Health, working with the State Board of Pharmacy, must annually identify up to 15 prescription drugs on which the state spends significant health care funds and whose wholesale acquisition cost has increased by 50% or more over five years or 15% or more over 12 months, spanning different drug classes
- The department must provide the list of identified drugs and their price increase percentages to the Attorney General and publish the information on its website
- The Attorney General must require manufacturers of identified drugs to submit justifications for their wholesale acquisition cost increases, including all contributing factors, the percentage attributable to each factor, and explanations of each factor's role
- The Attorney General, in consultation with the department, must report annually to the General Assembly by December 1 and post the report online; manufacturer-submitted information is exempt from open records laws and may not be released in a way that identifies individual drugs, manufacturers, or compromises proprietary information
- The Attorney General may bring civil action against noncompliant manufacturers, seeking injunctive relief, costs, attorneys' fees, and civil penalties of up to $10,000 per violation, with each failure to provide information constituting a separate violation
Legislative Description
Health; identification of high-cost prescription drugs for which the state expends significant health care funds; provide
Last Action
House Second Readers
2/21/2020
Full Bill Text
No bill text available